Thu, November 30, 2023
Wed, November 29, 2023
Tue, November 28, 2023
Mon, November 27, 2023
Fri, November 24, 2023
Wed, November 22, 2023
Tue, November 21, 2023

Ashwani Verma Upgraded (TEVA) to Strong Buy and Increased Target to $13 on, Nov 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-increased-target-to-13-on-nov-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ashwani Verma of UBS, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy and Increased Target from $11 to $13 on, Nov 27th, 2023.

Ashwani has made no other calls on TEVA in the last 4 months.



There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, 0 agree with Ashwani's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ashwani


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $13 on, Friday, September 8th, 2023

Publication Contributing Sources